These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9571964)

  • 1. [Essential conditions for the development of new anticancer drugs based on ICH-GCP].
    Saijo N
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):671-84. PubMed ID: 9571964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of an anticancer drug in Japan based on a new clinical trial system].
    Nakashima H; Nakano S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):287-94. PubMed ID: 9492818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction of new GCP (good clinical practice)].
    Miyake S
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):645-9. PubMed ID: 9571961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of nurses in clinical trials of anticancer drug development].
    Matsuura C
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):231-4. PubMed ID: 9987524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New Japanese GCP--from the standpoint of a sponsor].
    Ebi O
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of Japan to develop new anticancer agents].
    Sajjo N
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):242-6. PubMed ID: 8611054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems in conducting clinical trials for cancer patients].
    Kondo M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):151-5. PubMed ID: 8611042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
    Andoh M; Fujiwara Y; Shimada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current problems of early phase clinical trials for new anticancer agents in Japan].
    Nakagawa K; Fukuoka M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):925-9. PubMed ID: 10897223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improving the infrastructure for clinical trials in Japan].
    Nakano S
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):225-30. PubMed ID: 9987523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of new Japanese GCP on pharmaceutical-company-directed clinical trials and physician-directed clinical studies in the surgical field].
    Nakajima T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):685-90. PubMed ID: 9571965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience as a model hospital for new good clinical practice (GCP) regulations].
    Tanaka S
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1467-73. PubMed ID: 9725036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Has the clinical trials in Japan been accepted by the society?].
    Saijo S; Yoshida S
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):129-35. PubMed ID: 8611038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the evaluation of new cancer treatments: challenges and opportunities.
    Rothenberg ML; Carbone DP; Johnson DH
    Nat Rev Cancer; 2003 Apr; 3(4):303-9. PubMed ID: 12671669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New recommendations for evaluating the effectiveness of treatment of solid tumors and principles of the Guidelines for Clinical Practice (GCP)].
    Gorbunova VA; Orel NF; Zaruk VA
    Vopr Onkol; 2001; 47(6):718-21. PubMed ID: 11826496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan.
    Uyama Y; Shibata T; Nagai N; Hanaoka H; Toyoshima S; Mori K
    Clin Pharmacol Ther; 2005 Aug; 78(2):102-13. PubMed ID: 16084844
    [No Abstract]   [Full Text] [Related]  

  • 20. [How to establish GCP-units in Denmark?].
    Krogsgaard K; Andreasen PB
    Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.